Literature DB >> 20079747

Effect of troponin I Ser23/24 phosphorylation on Ca2+-sensitivity in human myocardium depends on the phosphorylation background.

Viola Kooij1, Martina Saes, Kornelia Jaquet, Ruud Zaremba, D Brian Foster, Anne M Murphy, Cris Dos Remedios, Jolanda van der Velden, Ger J M Stienen.   

Abstract

Protein kinase A (PKA)-mediated phosphorylation of Ser23/24 of cardiac troponin I (cTnI) causes a reduction in Ca(2+)-sensitivity of force development. This study aimed to determine whether the PKA-induced modulation of the Ca(2+)-sensitivity is solely due to cTnI phosphorylation or depends on the phosphorylation status of other sarcomeric proteins. Endogenous troponin (cTn) complex in donor cardiomyocytes was partially exchanged (up to 66+/-1%) with recombinant unphosphorylated human cTn and in failing cells similar exchange was achieved using PKA-(bis)phosphorylated cTn complex. Cardiomyocytes immersed in exchange solution without complex added served as controls. Partial exchange of unphosphorylated cTn complex in donor tissue significantly increased Ca(2+)-sensitivity (pCa(50)) to 5.50+/-0.02 relative to the donor control value (pCa(50)=5.43+/-0.04). Exchange in failing tissue with PKA-phosphorylated cTn complex did not change Ca(2+)-sensitivity relative to the failing control (pCa(50)=5.60+/-0.02). Subsequent treatment of the cardiomyocytes with the catalytic subunit of PKA significantly decreased Ca(2+)-sensitivity in donor and failing tissue. Analysis of phosphorylated cTnI species revealed the same distribution of un-, mono- and bis-phosphorylated cTnI in donor control and in failing tissue exchanged with PKA-phosphorylated cTn complex. Phosphorylation of myosin-binding protein-C in failing tissue was significantly lower compared to donor tissue. These differences in Ca(2+)-sensitivity in donor and failing cells, despite similar distribution of cTnI species, could be abolished by subsequent PKA-treatment and indicate that other targets of PKA are involved the reduction of Ca(2+)-sensitivity. Our findings suggest that the sarcomeric phosphorylation background, which is altered in cardiac disease, influences the impact of cTnI Ser23/24 phosphorylation by PKA on Ca(2+)-sensitivity. Copyright (c) 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20079747      PMCID: PMC2854313          DOI: 10.1016/j.yjmcc.2010.01.002

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  47 in total

Review 1.  Adrenergic and muscarinic receptors in the human heart.

Authors:  O E Brodde; M C Michel
Journal:  Pharmacol Rev       Date:  1999-12       Impact factor: 25.468

2.  Calcium sensitivity of force in human ventricular cardiomyocytes from donor and failing hearts.

Authors:  J van der Velden; N M Boontje; Z Papp; L J Klein; F C Visser; J W de Jong; V J Owen; P B J Burton; G J M Stienen
Journal:  Basic Res Cardiol       Date:  2002       Impact factor: 17.165

3.  PKC-alpha regulates cardiac contractility and propensity toward heart failure.

Authors:  Julian C Braz; Kimberly Gregory; Anand Pathak; Wen Zhao; Bogachan Sahin; Raisa Klevitsky; Thomas F Kimball; John N Lorenz; Angus C Nairn; Stephen B Liggett; Ilona Bodi; Su Wang; Arnold Schwartz; Edward G Lakatta; Anna A DePaoli-Roach; Jeffrey Robbins; Timothy E Hewett; James A Bibb; Margaret V Westfall; Evangelia G Kranias; Jeffery D Molkentin
Journal:  Nat Med       Date:  2004-02-15       Impact factor: 53.440

4.  Protein kinase C and A sites on troponin I regulate myofilament Ca2+ sensitivity and ATPase activity in the mouse myocardium.

Authors:  YeQing Pi; Dahua Zhang; Kara R Kemnitz; Hao Wang; Jeffery W Walker
Journal:  J Physiol       Date:  2003-08-15       Impact factor: 5.182

5.  The effect of myosin light chain 2 dephosphorylation on Ca2+ -sensitivity of force is enhanced in failing human hearts.

Authors:  J van der Velden; Z Papp; N M Boontje; R Zaremba; J W de Jong; P M L Janssen; G Hasenfuss; G J M Stienen
Journal:  Cardiovasc Res       Date:  2003-02       Impact factor: 10.787

6.  Phosphorylation of C-protein, troponin I and phospholamban in isolated rabbit hearts.

Authors:  J L Garvey; E G Kranias; R J Solaro
Journal:  Biochem J       Date:  1988-02-01       Impact factor: 3.857

7.  Increased Ca2+-sensitivity of the contractile apparatus in end-stage human heart failure results from altered phosphorylation of contractile proteins.

Authors:  J van der Velden; Z Papp; R Zaremba; N M Boontje; J W de Jong; V J Owen; P B J Burton; P Goldmann; K Jaquet; G J M Stienen
Journal:  Cardiovasc Res       Date:  2003-01       Impact factor: 10.787

8.  Protein kinase A phosphorylates titin's cardiac-specific N2B domain and reduces passive tension in rat cardiac myocytes.

Authors:  R Yamasaki; Y Wu; M McNabb; M Greaser; S Labeit; H Granzier
Journal:  Circ Res       Date:  2002-06-14       Impact factor: 17.367

9.  Increased protein kinase C activity and expression of Ca2+-sensitive isoforms in the failing human heart.

Authors:  N Bowling; R A Walsh; G Song; T Estridge; G E Sandusky; R L Fouts; K Mintze; T Pickard; R Roden; M R Bristow; H N Sabbah; J L Mizrahi; G Gromo; G L King; C J Vlahos
Journal:  Circulation       Date:  1999-01-26       Impact factor: 29.690

10.  Alterations in Ca2+ sensitive tension due to partial extraction of C-protein from rat skinned cardiac myocytes and rabbit skeletal muscle fibers.

Authors:  P A Hofmann; H C Hartzell; R L Moss
Journal:  J Gen Physiol       Date:  1991-06       Impact factor: 4.086

View more
  39 in total

1.  Tissue procurement strategies affect the protein biochemistry of human heart samples.

Authors:  Lori A Walker; Allen M Medway; John S Walker; Joseph C Cleveland; Peter M Buttrick
Journal:  J Muscle Res Cell Motil       Date:  2010-12-24       Impact factor: 2.698

2.  Top-down quantitative proteomics identified phosphorylation of cardiac troponin I as a candidate biomarker for chronic heart failure.

Authors:  Jiang Zhang; Moltu J Guy; Holly S Norman; Yi-Chen Chen; Qingge Xu; Xintong Dong; Huseyin Guner; Sijian Wang; Takushi Kohmoto; Ken H Young; Richard L Moss; Ying Ge
Journal:  J Proteome Res       Date:  2011-07-28       Impact factor: 4.466

Review 3.  Cardiac myosin-binding protein C: hypertrophic cardiomyopathy mutations and structure-function relationships.

Authors:  Vasco Sequeira; E Rosalie Witjas-Paalberends; Diederik W D Kuster; Jolanda van der Velden
Journal:  Pflugers Arch       Date:  2013-11-17       Impact factor: 3.657

4.  Combined troponin I Ser-150 and Ser-23/24 phosphorylation sustains thin filament Ca(2+) sensitivity and accelerates deactivation in an acidic environment.

Authors:  Benjamin R Nixon; Shane D Walton; Bo Zhang; Elizabeth A Brundage; Sean C Little; Mark T Ziolo; Jonathan P Davis; Brandon J Biesiadecki
Journal:  J Mol Cell Cardiol       Date:  2014-03-19       Impact factor: 5.000

Review 5.  The role of protein kinase C-mediated phosphorylation of sarcomeric proteins in the heart-detrimental or beneficial?

Authors:  Viola Kooij; Ger J M Stienen; Jolanda van der Velden
Journal:  Biophys Rev       Date:  2011-06-28

6.  Cardiac troponin I tyrosine 26 phosphorylation decreases myofilament Ca2+ sensitivity and accelerates deactivation.

Authors:  Hussam E Salhi; Shane D Walton; Nathan C Hassel; Elizabeth A Brundage; Pieter P de Tombe; Paul M L Janssen; Jonathan P Davis; Brandon J Biesiadecki
Journal:  J Mol Cell Cardiol       Date:  2014-09-22       Impact factor: 5.000

7.  Molecular effects of the myosin activator omecamtiv mecarbil on contractile properties of skinned myocardium lacking cardiac myosin binding protein-C.

Authors:  Ranganath Mamidi; Kenneth S Gresham; Amy Li; Cristobal G dos Remedios; Julian E Stelzer
Journal:  J Mol Cell Cardiol       Date:  2015-06-20       Impact factor: 5.000

8.  Length dependence of striated muscle force generation is controlled by phosphorylation of cTnI at serines 23/24.

Authors:  Laurin M Hanft; Brandon J Biesiadecki; Kerry S McDonald
Journal:  J Physiol       Date:  2013-07-08       Impact factor: 5.182

9.  Sex dimorphisms of crossbridge cycling kinetics in transgenic hypertrophic cardiomyopathy mice.

Authors:  Camille L Birch; Samantha M Behunin; Marissa A Lopez-Pier; Christiane Danilo; Yulia Lipovka; Chandra Saripalli; Henk Granzier; John P Konhilas
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-05-06       Impact factor: 4.733

10.  Sexually dimorphic myofilament function and cardiac troponin I phosphospecies distribution in hypertrophic cardiomyopathy mice.

Authors:  Laurel A K McKee; Hao Chen; Jessica A Regan; Samantha M Behunin; Jeffery W Walker; John S Walker; John P Konhilas
Journal:  Arch Biochem Biophys       Date:  2013-01-23       Impact factor: 4.013

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.